Ginkgo Bioworks Holdings (DNA)

Ginkgo Bioworks Holdings, Inc. is a U.S.-based life sciences tools and services company listed on the NYSE under the ticker DNA. The company develops a cell engineering platform that supports research, development, and commercialization of engineered organisms and related products. Its operations are organized into Cell Engineering and Biosecurity segments. Within cell engineering, Ginkgo provides R&D solutions and a set of tools that include functional genomics, antibody developability, small molecule developability, artificial intelligence models, and reconfigurable automation cart systems. Through its biosecurity activities, it offers biomonitoring and bioinformatics support via Canopy and digital surveillance, analytics, and insights through Horizon. The company also works in genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection, and plant trait optimization, serving customers in pharmaceuticals, biotechnology, agriculture, industrial and environmental markets, food and nutrition, consumer and technology, and government and defense.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.